Abstract:Background: Traumatic brain injury (TBI) is a major cause of morbidity and mortality, affecting millions annually worldwide. Although the majority of TBI patients return to premorbid baseline, a subset of patient can develop persistent and often debilitating neurocognitive and behavioral changes. The etiology of TBI within the clinical setting is inherently heterogenous, ranging from sport related injuries, fall related injuries and motor vehicle accidents in the civilian setting, to blast injuries in the military setting. Objective: Animal models of TBI, offer the distinct advantage of controlling for injury modality, duration and severity. Furthermore, preclinical models of TBI have provided the necessary temporal opportunity to study the chronic neuropathological sequelae of TBI, including neurodegenerative sequelae such as tauopathy and neuroinflammation within the finite experimental timeline. Despite the high prevalence of TBI, there are currently no disease modifying regimen for TBI, and the current clinical treatments remain largely symptom based. The preclinical models have provided the necessary biological substrate to examine the disease modifying effect of various pharmacological agents and have imperative translational value. Methods: The current review will include a comprehensive survey of well-established preclinical models, including classic preclinical models including weight drop, blast injury, fluid percussion injury, controlled cortical impact injury, as well as more novel injury models including closed-head impact model of engineered rotational acceleration (CHIMERA) models and closed-head projectile concussive impact model (PCI). In addition to rodent preclinical models, the review will include an overview of other species including large animal models and Drosophila . Results: There are major neuropathological perturbations post TBI captured in various preclinical models, which include neuroinflammation, calcium dysregulation, tauopathy, mitochondrial dysfunction and oxidative stress, axonopathy, as well as glymphatic system disruption. Conclusion: The preclinical models of TBI continue to offer valuable translational insight, as well as essential neurobiological basis to examine specific disease modifying therapeutic regimen.

Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside

Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases

'Comprehensive review of emerging drug targets in traumatic brain injury (TBI): challenges and future scope

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?

Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets

From spreading depolarization to blood-brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury

Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities

Cell Death and Recovery in Traumatic Brain Injury

Reactive gliosis in traumatic brain injury: a comprehensive review

Traumatic brain injury: Symptoms to systems in the 21st century

An overview of preclinical models of traumatic brain injury (TBI): relevance to pathophysiological mechanisms

The synapse in traumatic brain injury

The far-reaching scope of neuroinflammation after traumatic brain injury

The effect of traumatic brain injury on learning and memory: A synaptic focus

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Neuroinflammation Following Traumatic Brain Injury: Take It Seriously or Not

Traumatic Brain Injury: A Comprehensive Review of Biomechanics and Molecular Pathophysiology

Beyond the Brain: Peripheral Interactions after Traumatic Brain Injury

Potential Neuroprotective Role of Neurotrophin in Traumatic Brain Injury